VJOncology

Optimizing treatment in patients with early-stage HER2-positive breast cancer

Neoadjuvant therapy and organ preservation in rectal cancer

Side effects of chemotherapy vs. immunotherapy

FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancer

Bioimpedance spectroscopy for detection and early intervention of breast cancer-related lymphedema

Managing biochemical relapse after radical prostatectomy

Rituximab and its biosimilars: consistencies and advantages

Hydration and nutrition in end-of-life care

Intensity modulated radiotherapy (IMRT) for locally advanced lung cancer

Audit of rapid infusion of biosimilar rituximab

Non-operative management of rectal cancer

Optimal management of recurrent low grade endometrial cancer

scRNA-seq of UTUC reveals immune TME heterogeneity

Early diagnosis of lung cancer: AI, lung nodules, liquid biopsies

Improving breast cancer outcomes with NGS sequencing

MRI-targeted biopsies and overdiagnosis in prostate cancer

Prolonging the survival of high-grade glioma patients

How BMI influences endometrial cancer risk

Quality of life results from OlympiA

Future advances in DCIS: de-escalation of hormonal therapy

Potential role of rituximab in mCRPC

Molecular testing for adenocarcinoma and squamous cell lung cancer

Challenges of treating solid tumors

Kidney cancer: post-surgery sorafenib

Utilizing AI in precision medicine

SCLC hyperprogression with nivolumab

The significance of having a choir in providing supportive care

Stereotactic ablative radiotherapy (SABR) for lung cancer treatment

Late and long-lasting effects of cancer treatment

Differences in survival rates among non-urothelial bladder cancers

Potential of immunotherapy for kidney cancer

Next generation sequencing in lung cancer

How does pleural effusion influence the treatment and prognosis of lung cancer?

Assessing endpoints for patients treated with vorasidenib versus placebo for glioblastoma

Prostate cancer: high-res ultrasound vs MRI imaging

Treatment options for patients with bladder cancer, is bladder removal always necessary?

The predictive & prognostic value of genomic adjusted radiation dose (GARD) for oropharyngeal cancer

Management of pleural effusion in lung cancer

Radiotherapy for breast cancer increases risk of cardiovascular disease

The provision of nutritional advice and care for cancer patients

PRIMETEST: evaluating retroperitoneal lymph node dissection

The difficulties in treating bladder cancer with immunotherapy

Latest advances in radiotherapy for sarcoma

Combining cemiplimab and ISA101b for the treatment of recurrent/metastatic HPV16 cervical cancer

What to look forward to in breast cancer at ASCO 2023

Precision medicine for metastatic triple-negative breast cancer

Integrating cemiplimab + ISA101b into the treatment paradigm for recurrent HPV16 cervical cancer

Phase III trial of IMRT versus IMPT in oropharyngeal carcinoma

Taiwan national lung cancer early detection program for heavy smokers and those with family history

EU Cancer Plan and what it means for prostate cancer

The latest treatment options for BRCA-mutated breast cancer